Area of research
Oncology · Applied Mathematics
Research interest
Research interests include Medicine, Cancer research, Chimeric antigen receptor, Adverse effect, Immunotherapy, and Ovarian cancer.
Global knowledge graph of osteoporosis biomarkers based on large language model embeddings and complex network algorithms
Systematic analysis and prediction of the burden of Alzheimer’s disease and other dementias caused by hyperglycemia
Shengxue Busui Decoction activates the PI3K/Akt and VEGF pathways, enhancing vascular function and inhibiting osteocyte apoptosis to combat steroid-induced femoral head necrosis
Safety issues of tofacitinib in rheumatoid arthritis patients: real-world pharmacovigilance
Drug-induced pulmonary edema: a real-world pharmacovigilance study using the FDA Adverse Event Reporting System (FAERS)
Intratumoral delivery of PD-1/PD-L1 and CTLA-4 inhibitors for recurrent/refractory solid tumors: a proof-of-concept treatment strategy
NK-92MI Cells Engineered with Anti-claudin-6 Chimeric Antigen Receptors in Immunotherapy for Ovarian Cancer
Development of glypican-3-specific chimeric antigen receptor-modified natural killer cells and optimization as a therapy for hepatocellular carcinoma
Safety of TNF-α inhibitors: A real-world study based on the US FDA Adverse Event Reporting System Database
Adverse events associated with carbamazepine: a pharmacovigilance study using the FDA Adverse Event Reporting System
Apoptosis and NETotic cell death affect diabetic nephropathy independently: An study integrative study encompassing bioinformatics, machine learning, and experimental validation
Adverse reaction of specific acute kidney injury caused by atorvastatin: an actual study based on the database of the US FDA adverse event reporting system
Effective sequential combined therapy with carboplatin and a CDC7 inhibitor in ovarian cancer
Remodelling of tumour microenvironment by microwave ablation potentiates immunotherapy of AXL-specific CAR T cells against non-small cell lung cancer
IL-7 and CCL19-secreting CAR-T cell therapy for tumors with positive glypican-3 or mesothelin
Use of chimeric antigen receptor NK-92 cells to target mesothelin in ovarian cancer